中文产业新闻评分66Chinese source
鑫康合生物抗 IL-17A/F 抗体莱康奇塔单抗获 NMPA 批准，用于中重度斑块状银屑病
国内首款，鑫康合生物医药 1 类新药莱康奇塔单抗获批上市｜北极光·Family
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
国内首款，鑫康合生物医药 1 类新药莱康奇塔单抗获批上市｜北极光·Family
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.